Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.53 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.49 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL7297431 | 0.90 | HDAC2 (0.49) | PDPK1ADORA2AADORA1ALDH1A1HSP90AA1 | |
| SCHEMBL5692672 | 0.85 | PDPK1 (0.64) | PDPK1ADORA2AADORA1ALDH1A1HSP90AA1 | |
| SCHEMBL11159480 | 0.85 | PDPK1 (0.46) | PDPK1ADORA2AADORA1ALDH1A1HSP90AA1 | |
| SCHEMBL1951149 | 0.83 | PDPK1 (0.61) | PDPK1ADORA2AADORA1ALDH1A1HSP90AA1 | |
| SCHEMBL20689616 | 0.82 | PDPK1 (0.43) | PDPK1ADORA2AADORA1ALDH1A1HSP90AA1 | |
| SCHEMBL20092688 | 0.81 | MGAM (0.42) | PDPK1ADORA2AADORA1ALDH1A1HSP90AA1 | |
| SCHEMBL20609434 | 0.81 | PDPK1 (0.56) | PDPK1ADORA2AADORA1ALDH1A1HSP90AA1 | |
| SCHEMBL1047236 | 0.80 | PDPK1 (0.53) | PDPK1ADORA2AADORA1ALDH1A1RAB9A | |
| SCHEMBL31055003 | 0.79 | PDPK1 (0.52) | PDPK1ADORA2AADORA1ALDH1A1HSP90AA1 | |
| SCHEMBL3663189 | 0.78 | PDPK1 (0.47) | PDPK1ADORA2AADORA1ALDH1A1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024035207-A1 | ANTI-CORROSIVE CAPSULE, MANUFACTURING METHOD THEREFOR, BRAKE PAD, AND MANUFACTURING METHOD THEREFOR | 성균관대학교산학협력단 | 2024-02-15 | — | — | WO | claimed |
| WO-2023204651-A1 | BRAKE PAD COMPRISING ANTI-CORROSION ADDITIVE AND METHOD FOR MANUFACTURING SAME | 성균관대학교산학협력단 | 2023-10-26 | — | — | WO | claimed |
| EP-0871619-B1 | PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES | BOEHRINGER INGELHEIM PHARMA (US) | 2002-11-06 | — | — | EP | claimed |
| US-6288091-B1 | COMPOUNDS SUCH AS 2,2,2-TRICHLOROETHYL N-(4-(2-AMINO-4-THIAZOLYL)-PHENYL)CARBAMATE THAT INHIBIT THE HERPES HELCASE-PRIMASE ENZYME COMPLEX | BOEHRINGER INGELHEIM LTD. (CA) | 2001-09-11 | — | — | US | claimed |
| EP-0871619-A1 | PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 1998-10-21 | — | — | EP | claimed |
| WO-1997024343-A1 | PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1997-07-10 | — | — | WO | claimed |
| WO-1987002273-A1 | SEPARATION PROCESS | THE BRITISH PETROLEUM COMPANY P.L.C. (GB) | 1987-04-23 | — | — | WO | claimed |
| JP-4204648-A | — | — | None | — | — | JP | disclosed |
| US-20250326725-A1 | PI4-Kinase Inhibitors and Methods of Using the Same | UNIV LELAND STANFORD JUNIOR (US) | 2025-10-23 | — | — | US | disclosed |
| US-12415788-B2 | PI4-kinase inhibitors and methods of using the same | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-09-16 | — | — | US | disclosed |
| EP-3419980-B1 | PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY | UNIV LELAND STANFORD JUNIOR (US) | 2025-01-01 | — | — | EP | disclosed |
| WO-2024155066-A1 | ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODY WITH IMPROVED BLOOD-BRAIN-BARRIER PERMEABILITY, AND MULTISPECIFIC ANTIBODY AND PHARMACEUTICAL COMPOSITION USING SAME | 주식회사 시그널바이오 | 2024-07-25 | — | — | WO | disclosed |
| WO-2024035207-A1 | ANTI-CORROSIVE CAPSULE, MANUFACTURING METHOD THEREFOR, BRAKE PAD, AND MANUFACTURING METHOD THEREFOR | 성균관대학교산학협력단 | 2024-02-15 | — | — | WO | disclosed |
| EP-0315178-A2 | Process for producing a urethane and a carbonic acid ester | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1989-05-10 | — | — | EP | disclosed |
| EP-0263020-A1 | 4-Phenyl thiazole derivatives | LABORATOIRE L. LAFON Société anonyme dite: (FR) | 1988-04-06 | — | — | EP | disclosed |
| WO-1987002273-A1 | SEPARATION PROCESS | THE BRITISH PETROLEUM COMPANY P.L.C. (GB) | 1987-04-23 | — | — | WO | disclosed |
| EP-0062825-B1 | WATER-SOLUBLE TRIAZINE COMPOUNDS, THEIR PREPARATION AND THEIR USE | BAYER AG (DE) | 1987-03-11 | — | — | EP | disclosed |
| EP-0062825-A2 | Water-soluble triazine compounds, their preparation and their use | BAYER AG (DE) | 1982-10-20 | — | — | EP | disclosed |
| EP-0021806-A1 | 2,3-Dihydro-imidazo (2,1-b) benzothiazole derivatives and pharmaceutical compositions containing them | JANSSEN PHARMACEUTICA N.V. (BE) | 1981-01-07 | — | — | EP | disclosed |
| EP-0015361-A1 | Cumarinic pigments, process for their preparation and their use | Montedison S.p.A. (IT) | 1980-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250326725-A1 | PI4-Kinase Inhibitors and Methods of Using the Same | PI4KB, PI4KA, PI4K2A | PDPK1 43/4885ADORA2A 3328/4885ADORA1 3618/4885 |
| US-12415788-B2 | PI4-kinase inhibitors and methods of using the same | PI4KB, PI4KA, PI4K2A | PDPK1 43/4885ADORA2A 3328/4885ADORA1 3618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.